RESEARCH-USE BIOSIMILAR ANTIBODY
Apamistamab
Monoclonal antibody · IgG1
Apamistamab is a CHO-expressed human antibody that targets PTPRC/CD45. Apamistamab carries a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 146.52 kDa. The isotype control for Apamistamab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
TARGETCD45
YMonoclonal antibody
CATALOGSC-BS-769
CATALOG NUMBERSC-BS-769
MOLECULAR WEIGHTApprox. 146.112 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Apamistamab is a CHO-expressed human antibody that targets PTPRC/CD45. Apamistamab carries a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 146.52 kDa. The isotype control for Apamistamab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
Apamistamab is a recombinant research-use antibody directed against CD45.